Mounjaro®
Starting from £179.99/mo
Start journey Learn moreKnowing when to stop taking Mounjaro is a clinical decision, not a personal one you should make alone. In most cases, treatment continues for as long as it is working, well tolerated and clinically appropriate — but there are specific circumstances in which your prescriber will recommend pausing or ending it. This guide walks through each of those situations, drawing on NICE's appraisal of tirzepatide (TA1026) and the medicine's licensed criteria, so you can approach that conversation informed. Mounjaro is a Prescription-Only Medicine; every decision about your treatment plan belongs with a GPhC-registered prescriber who knows your full picture.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
NICE recommends reviewing Mounjaro if a person has not lost at least 5% of their starting body weight after six months at the highest dose they can tolerate. That threshold exists because, for people the medicine does not suit, continuing carries real costs (financial, physical and psychological) for little measurable benefit.
This is a question our prescribers hear most weeks: "How do I know if it's working enough?" The honest answer is that six months gives the medicine a fair trial. If the 5% mark has not been reached by that point, continuing at the same dose is unlikely to change the outcome. The right move is a prescriber review, not an extended wait.
It is worth being realistic about what "not working" means. Slow progress in the first eight to twelve weeks is common while the dose is still being increased — you can read more about the expected timeline on how long Mounjaro takes to work. The NICE threshold applies at the highest tolerated dose, not during the titration period. If you're stalling and wondering why, eating very little on Mounjaro but not losing weight covers the main clinical reasons that can happen.
Some events mean stopping promptly, without waiting for a scheduled review. The NHS medicines page for tirzepatide lists the situations that require you to stop and seek help: a severe allergic reaction, signs of acute pancreatitis (severe stomach pain that radiates to the back, with or without vomiting), or gallbladder problems. Pregnancy is another clear stop point, Mounjaro is not recommended during pregnancy, breastfeeding, or in the period when you are actively trying to conceive.
Less acute but equally firm reasons to stop: a diagnosis that is itself a contraindication (such as medullary thyroid carcinoma or MEN2), or a new medicine that interacts in a way that cannot be safely managed. This is precisely why a prescriber reviews your record before every repeat, so that a change in your health does not go unnoticed between orders.
If you're ever unsure mid-treatment about a symptom or a new diagnosis, our support team is available seven days a week and can escalate to a prescriber the same day.
Some people reach a weight that feels right, sustain it for several months, and begin to ask whether they still need the medicine. That is a reasonable question, not a failure of commitment. When you stop taking Mounjaro, the hormonal signals that were suppressing appetite return to their pre-treatment levels over several weeks. For many people, appetite increases again and weight gradually comes back, the extent varies between individuals and depends heavily on the lifestyle changes built during treatment.
There is no universally "right" point to stop. Some people continue at a maintenance dose indefinitely, because obesity is a chronic condition. Others reduce to the lowest effective dose and monitor carefully. What matters is that this conversation happens with your prescriber, not unilaterally. Stopping Mounjaro for weight loss has its own considerations around planning, and whether you can just stop taking Mounjaro covers the safety question directly.
For a broader look at what the treatment journey involves from start to finish, what to expect when taking Mounjaro is a useful reference.
Mounjaro is sometimes paused rather than permanently stopped. Planned surgery is one reason, NHS England advises telling your healthcare team, including the anaesthetist, that you are taking a GLP-1 medicine before any procedure, and some surgical teams will ask you to stop in advance. Pregnancy planning is another: MHRA guidance recommends using effective contraception while on tirzepatide and observing a wash-out period before trying to conceive.
Financial or personal circumstances sometimes lead people to pause treatment too. There is no medical harm in stopping Mounjaro when you are ready to, as long as you have a plan for what happens to appetite and weight in the weeks that follow. How to stop taking Mounjaro covers the practical steps for a managed pause.
If cost context is relevant to your thinking, Mounjaro price comparison in the UK sets out the honest market picture. At nume, we review every repeat order clinically before it is dispensed, if your circumstances have changed, that conversation can happen at the same point. Check your eligibility if you're considering starting or restarting treatment.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.